Isaac Stoner

Chief Executive Officer at

Mindimmune Therapeutics, Inc.

Consumer Services

Health Technology

Profile

Mr. Isaac Stoner is a Chief Executive Officer & Director at Mindimmune Therapeutics, Inc. He is on the Board of Directors at Mindimmune Therapeutics, Inc. Mr. Stoner was previously employed as a President, Chief Executive Officer & Director by Octagon Therapeutics, Inc. He received his undergraduate degree from Brown University and an MBA from MIT Sloan School of Management.

Isaac Stoner active positions

Companies	Position	Start
Mindimmune Therapeutics, Inc. Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system	Chief Executive Officer	24/11/2025

All active positions of Isaac Stoner

Former positions of Isaac Stoner

Companies	Position	End
Octagon Therapeutics, Inc. Octagon Therapeutics, Inc. BiotechnologyHealth Technology Develops antibiotics and medicines based on novel metabolic targets in disease-causing bacteria, lymphocytes, and cancer cells	Chief Executive Officer	02/01/2025

See the detail of Isaac Stoner's experience

Training of Isaac Stoner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Isaac Stoner's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Brown University Brown University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
MIT Sloan School of Management MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Mindimmune Therapeutics, Inc. Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system	Health Technology
Octagon Therapeutics, Inc. Octagon Therapeutics, Inc. BiotechnologyHealth Technology Develops antibiotics and medicines based on novel metabolic targets in disease-causing bacteria, lymphocytes, and cancer cells	Health Technology